Perspectives
Perspectives
Private Equity in GI
The impact of private equity in GI is still being written, and while many have embraced this business model, others have been critical of its...
Pearls from the Pros
Iron Overload in Non-HFE Liver Disease: Not all Iron is Ready to Strike
In any patient with chronic liver disease, an elevated serum ferritin or an elevated iron saturation should prompt testing for HFE mutations to...
Commentary
The Breakthrough Drug Whose Full Promise Remains Unrealized
With its approval in 2013, sofosbuvir revolutionized the treatment of hepatitis C, but the goal of eliminating this disease is still decades away...
Perspectives
Exploring the impact of substance use on liver transplantation
The ethics of liver transplantation in the setting of severe alcohol-associated hepatitis are complex and still controversial.
Perspectives
Coping with burnout and repetitive injuries
In this column we explore two different impediments to longevity as a gastroenterologist: work-related disability and burnout.
Perspectives
Surveillance colonoscopy: When and how to stop
There is an ongoing debate about whether older adults should undergo CRC screening.
Perspectives
Pancreas cysts – What’s the best approach?
There have been a variety of expert recommendations and guidelines, but heterogeneity exists in management especially regarding timing of...
Perspectives
Evolutions in endoscopy
Our guest authors share their experiences performing minimally invasive alternatives to surgery, discussing both sides of gastrointestinal...
Perspectives
Weight loss management ... a new frontier?
How do we choose from this growing armamentarium of minimally invasive procedures and weight loss medicines? What combination is best? And what...
Perspectives
Innovation in GI: What’s the next big thing?
What’s the next big disruption in GI, and how will it impact us? Two experts present their thoughts on current hot topics in GI.